Kouki Harasaki

Bioluminescence Ventures is a leading biotechnology venture capital firm that invests in the future of medicine.

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Raised $189,500,000.00 from MQB Partners, Lightstone Ventures, Bioluminescence Ventures, Gates Frontier Fund, LifeRock Ventures, Google Ventures, Double Point Ventures, Agent Capital, Foresite Capital and Gates Frontier Fund.

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Raised $58,000,000.00 from Camford Capital, Piedmont Capital, Green D Ventures, Intuitive Ventures, Alumni Ventures, Cancer Research Institute, Castor Ventures, Pitango VC, Khosla Ventures and DHVC.

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

Raised $205,000,000.00 from Delos Capital, Bioluminescence Ventures, Kite Pharma, SymBiosis LLC, Catalio Capital Management, Solasta Ventures, Qatar Investment Authority, Mirae Asset, 5AM Ventures and Alexandria Venture Investments.

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

Raised $109,000,000.00 from Bioluminescence Ventures.

Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.

Raised $460,000,000.00 from HBM Healthcare Investments.

M12 is the venture capital arm of Microsoft that invests in early-stage companies.